Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities

Authors

Jeff M. Michalski, Washington University School of Medicine in St. Louis
et al

Journal

Advances in radiation oncology

Publication Date

2018

Volume

3

Issue

3

Inclusive Pages

405-411

Document Type

Open Access Publication

DOI

10.1016/j.adro.2018.04.010

Rights and Permissions

Xiao C, Moughan J, Movsas B, et al (2018) Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. Advances in Radiation Oncology, 3(3):405-411. https://doi.org/10.1016/j.adro.2018.04.010 © 2018 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Michalski, Jeff M. and et al, "Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities." Advances in radiation oncology. 3, 3. 405-411. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7051